Gsa Capital Partners LLP
- SEC CIK
- 0001362033
- Latest filing
- Aug 6, 2026
IMVT holding history
Immunovant, Inc. in every 13F filed by Gsa Capital Partners LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IMVT overviewAll 13F holders of IMVTFull Q2 2026 holdings
- Shares (Q2 2026)
- 65,267
- Value
- $2.52M
- % of portfolio
- 0.2%
- Quarters held
- 12
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 65,267 | $2.52M | 0.2% | −7,553−10.4% | Reduced | Holders |
| Q1 2026 | 72,820 | $1.81M | 0.1% | +28,680+65.0% | Added | Holders |
| Q4 2025 | 44,140 | $1.12M | 0.1% | +16,992+62.6% | Added | Holders |
| Q3 2025 | 27,148 | $438.0K | <0.1% | +27,148 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −24,634−100.0% | Sold out | Holders |
| Q3 2024 | 24,634 | $702.0K | 0.1% | +9,810+66.2% | Added | Holders |
| Q2 2024 | 14,824 | $391.0K | <0.1% | +14,824 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −8,760−100.0% | Sold out | Holders |
| Q4 2023 | 8,760 | $369.0K | <0.1% | +8,760 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −32,736−100.0% | Sold out | Holders |
| Q2 2023 | 32,736 | $621.0K | 0.1% | +32,736 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −95,146−100.0% | Sold out | Holders |
| Q3 2022 | 95,146 | $531.0K | 0.1% | +55,329+139.0% | Added | Holders |
| Q2 2022 | 39,817 | $155.0K | <0.1% | +39,817 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −40,654−100.0% | Sold out | Holders |
| Q4 2021 | 40,654 | $346.0K | <0.1% | −40,516−49.9% | Reduced | Holders |
| Q3 2021 | 81,170 | $705.0K | 0.1% | +81,170 | New | Holders |